CIK 0002056611 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Latigo Biotherapeutics, Inc.
Sign in to watch- Ticker
- LTGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832625838
- Phone
- 805-716-2927
- Business address
- 1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion | +296,880 | 3,414,544 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −3,117,664 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −445,320 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −1,125,823 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −742,201 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −3,117,664 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −296,880 | 0 | ||
| 2026-08-10 | Foresite Capital Management V, LLC 10% owner | Conversion · Convertible Promissory Note | −195,776 | 0 | ||
| 2026-08-06 | SMITH TODD N Director | Grant or award · Director Stock Option (right to buy) | +105,542 | 105,542 |
Page 4 of 4 · 69 trades